Shopping Cart
- Remove All
Your shopping cart is currently empty
NCC007 is a novel CKIα and CKIδ dual inhibitors by structural modification of N9 and C2 position of longdaysin.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 10 mg | $41 | In Stock | |
| 25 mg | $75 | In Stock | |
| 50 mg | $125 | In Stock | |
| 100 mg | $183 | In Stock | |
| 200 mg | $265 | In Stock | |
| 1 mL x 10 mM (in DMSO) | $30 | In Stock |
| Description | NCC007 is a novel CKIα and CKIδ dual inhibitors by structural modification of N9 and C2 position of longdaysin. |
| Targets&IC50 | CKIδ:3.6 μM, CKIα:1.8 μM |
| In vitro | In vitro kinase assay showed that NCC007 inhibited CKIα and CKIδ with an IC50 of 1.8 and 3.6 μM. |
| In vivo | NCC007 lengthened the period of mouse behavioral rhythms in vivo. |
| Molecular Weight | 447.5 |
| Formula | C22H28F3N7 |
| Cas No. | 2342583-66-6 |
| Smiles | CC(C1CC1)n1cnc2c(NCc3cccc(c3)C(F)(F)F)nc(NCCN(C)C)nc12 |
| Relative Density. | 1.36 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 120 mg/mL (268.16 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.